pocketful logo light
pocketful logo light
Aarey Drugs & Pharmaceuticals Ltd logo

Aarey Drugs & Pharmaceuticals Ltd

NSE: AAREYDRUGS BSE: 524412

₹102.75

(0.22%)

Sat, 26 Sept 2026, 03:53 am

Aarey Drugs & Pharmaceuticals Share Price Live Chart

1 Day

(0.22%)

No Result Found

Summary

  • Market Cap (in Cr)

    217.62

  • Net Profit (in Cr)

    4.02

  • P/B

    0.72

  • Sector P/E

    44.89

  • P/E

    23.91

  • EV/EBITDA

    10.16

  • Debt/Equity (Industry)

    0.17

  • Interest Cover (Industry)

    18.17

  • ROCE (Industry)

    20.59

  • RONW (Industry)

    17.62

  • ROE

    2.96

  • ROCE

    6.38

  • Debt/Equity

    0.24

  • EPS (TTM)

    1.21

  • Dividend Yield

    0

  • Book Value

    51.13

  • Interest Cover

    2.31

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters37.7139.0544.8044.8044.80
FII4.183.861.131.972.34
DII1.620000
Public56.4957.0954.0753.2352.86
Government00000

Read More

Technical Analysis

RSI

65.82

MACD

4.37

50 DMA

87.26

200 DMA

77.84

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic117.40101.0094.6184.6078.2168.2051.80
Fibonacci101.0094.7490.8784.6078.3474.4768.20
Camarilla92.7291.2289.7184.6086.7185.2083.70

Pivots Level: Classic

R3

+32.80

117.40

R2

+16.40

101.00

R1

+10.00

94.61

84.60
84.60
Pivot Point
LTP: 101.57

S1

-6.40

78.21

S2

-16.40

68.20

S3

-32.80

51.80

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    100.43

  • 20-EMA

    97.19

  • 30-EMA

    94.44

  • 50-EMA

    90.84

  • 100-EMA

    86.14

  • 200-EMA

    80.98

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
29 May 2026board-meetingsAccounts, Quarterly Results
11 Feb 2026board-meetingsQuarterly Results
13 Nov 2025board-meetingsQuarterly Results, Half Yearly Results
09 Sept 2025agm
04 Dec 2024egm
06 Sept 2024agm
23 Aug 2024agmAnnual General Meeting24 Sept 2024
06 Dec 2023egm
31 Jul 2023agm
29 Jul 2023agmAnnual General Meeting30 Aug 2023

Read More

Peer Comparison

Aarey Drugs & Pharmaceuticals Ltd logo

Aarey Drugs & Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Read More

Aarey Drugs & Pharmaceuticals Ltd About

Aarey Drugs & Pharmaceuticals in the manufacturing and trading of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and specialty chemi'cals.

Industry

Pharmaceuticals - Indian - Bulk Drugs

Founded

1990

Headquarters

CEO

Mihir R Ghatalia

Employees

Contact

Website icon

Website

http://www.aareydrugs.com

Email icon

Email

investorgrievance@aareydrugs.com

Phone icon

Phone

91-22-23455543

Location icon

Location

E-34 MIDC Tarapur, Boisar, Thane, Maharashtra, 401506

Read More

Aarey Drugs & Pharmaceuticals Ltd Company History

YearHistory
1990
  • The company was originally incorporated as a private limited company in the name of Niharika Textiles & Chemicals Pvt. Ltd. on May 15, 1990.
1993
  • The Aarey group of companies took over the company and converted it into a public limited company on March 18, 1993
  • The company's name was changed to Aarey Drugs & Pharmaceuticals Ltd.
2008
  • Aarey Drugs & Pharmaceuticals Ltd appointed Mr. Chetan Kiritbhai Mehta as an Independent Director from June 02, 2008.
2012
  • Aarey Drugs & Pharmaceuticals Ltd issued rights in the ratio of 2:1
  • Aarey Drugs & Pharmaceuticals Ltd gave a bonus in the ratio of 1:5
2017
  • The company commenced production of Mefanamic Acid and received confirmed orders from customers until October 2017.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
SHAH SANJAY JAYKANTbulkBuy15000081.5117 Apr 2026
INARAA FINANCIAL SERVICES PRIVATE LIMITEDbulkSell14300066.9517 Feb 2026
SHREE SALASAR PROPERTIES & FIN.(P)LTD.bulkBuy25000070.3312 Feb 2026
NISHITH ATULBHAI SHAHbulkSell25814570.5412 Feb 2026
NISHITH ATULBHAI SHAHbulkBuy8712768.9512 Feb 2026
NISHITH ATULBHAI SHAHbulkSell5343936711 Feb 2026
SHREE SALASAR PROPERTIES & FIN.(P)LTD.bulkBuy2500006811 Feb 2026
INARAA FINANCIAL SERVICES PRIVATE LIMITEDbulkBuy1436986611 Feb 2026
INARAA FINANCIAL SERVICES PRIVATE LIMITEDbulkSell6986711 Feb 2026
ARCHANA PRAMOD WANIbulkSell22500068.6307 Jan 2026

Read More

Aarey Drugs & Pharmaceuticals Ltd News

Aarey Drugs sets AGM book closure dates

Aarey Drugs & Pharmaceuticals has announced the book closure period for its 36th Annual General Meeting. The registers will remain closed from September 24 to September 30, 2026.

08 Sept 2026

companies

Aarey Drugs board meets on May 29

Aarey Drugs & Pharmaceuticals Ltd. board meets on May 29, 2026, to consider Q4 and FY26 audited results. Trading window closed.

25 May 2026

companies

Aarey Drugs Submits Q4 FY26 Compliance Certificate

Aarey Drugs & Pharmaceuticals submitted its quarterly compliance certificate under SEBI regulations for quarter ended March 31, 2026, confirming proper handling of dematerialised securities.

14 Apr 2026

companies

Aarey Drugs Q3FY26 Revenue Drops 28% to ₹9,642.63 Lakhs

Aarey Drugs & Pharmaceuticals reported Q3FY26 revenue of ₹9,642.63 lakhs, down from ₹13,378.86 lakhs in Q3FY25. Net profit declined to ₹56.95 lakhs from ₹71.80 lakhs year-on-year.

11 Feb 2026

co actions results

Aarey Drugs Reports Q2 FY2026 Financial Results with Fixed Asset Purchases

Aarey Drugs and Pharmaceuticals Limited approved its unaudited financial results for the quarter and half year ended September 30, 2025, along with statements of assets, liabilities, and cash flow. The company purchased certain fixed assets during the reporting period that are not yet ready for intended use, with depreciation to commence once assets are fully installed and commissioned.

13 Nov 2025

earnings

Read More

Frequently Asked Questions

  • 1.What is the stock price of Aarey Drugs & Pharmaceuticals Ltd?

    As of 26/09/2026 at 9:23 AM, Aarey Drugs & Pharmaceuticals Ltd shares are trading at ₹102.75.

  • 2.What is the market cap. of Aarey Drugs & Pharmaceuticals Ltd?

    As of 26/09/2026, the market capitalization of Aarey Drugs & Pharmaceuticals Ltd is ₹289.38 crore.

  • 3.When was Aarey Drugs & Pharmaceuticals Ltd founded?

    Aarey Drugs & Pharmaceuticals Ltd was founded in 1990.

  • 4.What are the P/E and P/B ratios of Aarey Drugs & Pharmaceuticals Ltd?

    As of 26/09/2026, Aarey Drugs & Pharmaceuticals Ltd has a P/E ratio of 70.04 and a P/B ratio of 0.72.

  • 5.How can I buy shares of Aarey Drugs & Pharmaceuticals Ltd?

    You can buy shares of Aarey Drugs & Pharmaceuticals Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Aarey Drugs & Pharmaceuticals Ltd?

    As of March,2026, promoters hold 37.71% in Aarey Drugs & Pharmaceuticals Ltd, while FIIs, DIIs and public shareholders hold 4.18%, 1.62% and 56.49%, respectively.

  • 7.Does Aarey Drugs & Pharmaceuticals Ltd pay dividends?

    No, Aarey Drugs & Pharmaceuticals Ltd does not pay dividends to eligible shareholders currently.

  • 8.What are the latest financial results of Aarey Drugs & Pharmaceuticals Ltd?

    For January,2024, Aarey Drugs & Pharmaceuticals Ltd reported revenue of ₹472.00 crore and a net profit of ₹4.02 crore.

  • 9.What is the Stock symbol of Aarey Drugs & Pharmaceuticals Ltd?

    AAREYDRUGS is the stock symbol of Aarey Drugs & Pharmaceuticals Ltd.

  • 10.Who is the CEO of Aarey Drugs & Pharmaceuticals Ltd?

    The CEO of Aarey Drugs & Pharmaceuticals Ltd is Mihir R Ghatalia.